{"version": "1.1.0", "data": "The drug ketamine has been used for medical purposes since it was developed in the 1960s, but it is perhaps more widely known for its illicit use as a hallucinogenic tranquiliser. Now we\u2019re beginning to realise the drug may have a future life as an alternative treatment for depression.\n\nKetamine is an approved anaesthetic drug, which can be used on its own, or in smaller doses in combination with other anaesthetics. Given under medical supervision, ketamine has powerful pain-killing properties and can also be used for mild sedation \u2013 for instance, for children who need to undergo multiple sessions of radiotherapy. \n\nUnder medical supervision, ketamine is very safe but in high doses, it can induce unwanted side effects such as hallucinations. \n\n## A better antidepressant?\n\nKetamine has powerful effects on the brain receptors for glutamate, the main chemical in the brain responsible for the activation of nerve cells. \n\nThis differs to current antidepressant medications, which mainly work on the serotonin and noradrenaline systems. Traditional antidepressants often take days to weeks for the effects to be seen. And only half of depressed people will respond to a trial of antidepressant medication. \n\nThis led Dr Robert Berman and his colleagues at Yale University to investigate the antidepressant properties of ketamine. In 2000, he published a small proof-of-concept study of seven depressed patients. They were all given a single, relatively small dose of ketamine (less than an anaesthetic dose), which was administered intravenously over 40 minutes. \n\nThe results were impressive, with rapid antidepressant effects that were obvious after 24 hours and increased further up to three days after treatment. \n\nEarly trials of intravenously-delivered ketamine have shown promising results. Image from shutterstock.com\n\nOn the down side, the drug caused some psychiatric side effects such as altered perception or hallucinations, though these resolved within the first two hours.\n\nThese very promising early results have been replicated in subsequent trials, which have shown that 70% of depressed participants responded to a single treatment with ketamine. \n\nSome overseas studies even reported that depressed patients who had failed to respond to electroconvulsive therapy, currently the strongest physical treatment we have for depression, may yet respond to ketamine treatment.\n\n## Next steps\n\nMy colleagues and I at the University of New South Wales and Black Dog Institute recently commenced the first Australian clinical trial testing the use of ketamine to treat depression, based at the Wesley Hospital in Kogarah. We\u2019re trialling the effects of different doses of ketamine on volunteers who are clinically depressed and have failed to get better with other antidepressant treatments. \n\nResults in the first eight volunteers have been encouraging, with all but one showing an improvement in mood. As found in the US trials, the response occurred rapidly, within a day of treatment. \n\nBut the trials so far have found that some people may relapse after a few days. So our research is also examining ways of making the response more lasting.\n\nAt this stage, it\u2019s unclear whether ketamine may emerge as a useful stand-alone treatment, or as an adjunct to other treatments. \n\nBut we\u2019re hoping that in future, ketamine may be useful to induce a rapid antidepressant response in urgent situations \u2013 where the patient is seriously depressed and acutely suicidal \u2013 and where other antidepressant treatments have failed. \n\nTo get involved in the study or find out more, click here.\n", "attributes": {"entities": {"type": "list", "itemType": "entities", "items": [{"mentions": [{"startOffset": 4, "endOffset": 17}], "type": "SUBSTANCE", "entityId": "Q243547"}, {"mentions": [{"startOffset": 36, "endOffset": 52}], "type": "TREATMENT", "entityId": "Q179661"}, {"mentions": [{"startOffset": 151, "endOffset": 165}], "type": "SUBSTANCE", "entityId": "Q194270"}, {"mentions": [{"startOffset": 166, "endOffset": 178}], "type": "SUBSTANCE", "entityId": "Q1941660"}, {"mentions": [{"startOffset": 215, "endOffset": 219}], "type": "SUBSTANCE", "entityId": "Q8386"}, {"mentions": [{"startOffset": 261, "endOffset": 270}], "type": "TREATMENT", "entityId": "Q179661"}, {"mentions": [{"startOffset": 275, "endOffset": 285}], "type": "DISEASE", "entityId": "Q4340209"}, {"mentions": [{"startOffset": 288, "endOffset": 296}], "type": "SUBSTANCE", "entityId": "Q243547"}, {"mentions": [{"startOffset": 312, "endOffset": 328}], "type": "SUBSTANCE", "entityId": "Q4990531"}, {"mentions": [{"startOffset": 406, "endOffset": 418}], "type": "SUBSTANCE", "entityId": "Q4990531"}, {"mentions": [{"startOffset": 453, "endOffset": 461}], "type": "SUBSTANCE", "entityId": "Q243547"}, {"mentions": [{"startOffset": 475, "endOffset": 479}], "type": "SYMPTOM", "entityId": "Q81938"}, {"mentions": [{"startOffset": 608, "endOffset": 620}], "type": "TREATMENT", "entityId": "Q180507"}, {"mentions": [{"startOffset": 651, "endOffset": 659}], "type": "SUBSTANCE", "entityId": "Q243547"}, {"mentions": [{"startOffset": 715, "endOffset": 727}], "type": "SYMPTOM", "entityId": "Q2047938"}, {"mentions": [{"startOffset": 736, "endOffset": 750}], "type": "SYMPTOM", "entityId": "Q130741"}, {"mentions": [{"startOffset": 766, "endOffset": 780}], "type": "SUBSTANCE", "entityId": "Q76560"}, {"mentions": [{"startOffset": 783, "endOffset": 791}], "type": "SUBSTANCE", "entityId": "Q243547"}, {"mentions": [{"startOffset": 820, "endOffset": 835}], "type": "SUBSTANCE", "entityId": "Q1187783"}, {"mentions": [{"startOffset": 840, "endOffset": 849}], "type": "SUBSTANCE", "entityId": "Q181136"}, {"mentions": [{"startOffset": 860, "endOffset": 868}], "type": "SUBSTANCE", "entityId": "Q79529"}, {"mentions": [{"startOffset": 916, "endOffset": 927}], "type": "SUBSTANCE", "entityId": "Q43054"}, {"mentions": [{"startOffset": 955, "endOffset": 969}], "type": "SUBSTANCE", "entityId": "Q76560"}, {"mentions": [{"startOffset": 970, "endOffset": 981}], "type": "TREATMENT", "entityId": "Q12140"}, {"mentions": [{"startOffset": 1008, "endOffset": 1017}], "type": "SUBSTANCE", "entityId": "Q167934"}, {"mentions": [{"startOffset": 1022, "endOffset": 1035}], "type": "SUBSTANCE", "entityId": "Q186242"}, {"mentions": [{"startOffset": 1057, "endOffset": 1072}], "type": "SUBSTANCE", "entityId": "Q76560"}, {"mentions": [{"startOffset": 1187, "endOffset": 1201}], "type": "SUBSTANCE", "entityId": "Q76560"}, {"mentions": [{"startOffset": 1202, "endOffset": 1212}], "type": "TREATMENT", "entityId": "Q12140"}, {"mentions": [{"startOffset": 1225, "endOffset": 1227}], "type": "TITLE", "entityId": "Q4618975"}, {"mentions": [{"startOffset": 1228, "endOffset": 1241}], "type": "PER", "entityId": "E140"}, {"mentions": [{"startOffset": 1264, "endOffset": 1279}], "type": "ORG", "entityId": "Q49112"}, {"mentions": [{"startOffset": 1299, "endOffset": 1313}], "type": "SUBSTANCE", "entityId": "Q76560"}, {"mentions": [{"startOffset": 1328, "endOffset": 1336}], "type": "SUBSTANCE", "entityId": "Q243547"}, {"mentions": [{"startOffset": 1475, "endOffset": 1483}], "type": "SUBSTANCE", "entityId": "Q243547"}, {"mentions": [{"startOffset": 1498, "endOffset": 1509}], "type": "SUBSTANCE", "entityId": "Q4990531"}, {"mentions": [{"startOffset": 1613, "endOffset": 1627}], "type": "SUBSTANCE", "entityId": "Q76560"}, {"mentions": [{"startOffset": 1714, "endOffset": 1723}], "type": "TREATMENT", "entityId": "Q179661"}, {"mentions": [{"startOffset": 1767, "endOffset": 1775}], "type": "SUBSTANCE", "entityId": "Q243547"}, {"mentions": [{"startOffset": 1857, "endOffset": 1861}], "type": "SUBSTANCE", "entityId": "Q12140"}, {"mentions": [{"startOffset": 1886, "endOffset": 1898}], "type": "SYMPTOM", "entityId": "Q2047938"}, {"mentions": [{"startOffset": 1907, "endOffset": 1925}], "type": "SYMPTOM", "entityId": "Q852859"}, {"mentions": [{"startOffset": 1929, "endOffset": 1943}], "type": "SYMPTOM", "entityId": "Q130741"}, {"mentions": [{"startOffset": 2148, "endOffset": 2157}], "type": "TREATMENT", "entityId": "Q179661"}, {"mentions": [{"startOffset": 2163, "endOffset": 2171}], "type": "SUBSTANCE", "entityId": "Q243547"}, {"mentions": [{"startOffset": 2264, "endOffset": 2289}], "type": "TREATMENT", "entityId": "Q131543"}, {"mentions": [{"startOffset": 2315, "endOffset": 2333}], "type": "TREATMENT", "entityId": "Q1427967"}, {"mentions": [{"startOffset": 2346, "endOffset": 2356}], "type": "DISEASE", "entityId": "Q4340209"}, {"mentions": [{"startOffset": 2377, "endOffset": 2385}], "type": "SUBSTANCE", "entityId": "Q243547"}, {"mentions": [{"startOffset": 2386, "endOffset": 2395}], "type": "TREATMENT", "entityId": "Q179661"}, {"mentions": [{"startOffset": 2440, "endOffset": 2469}], "type": "ORG", "entityId": "Q734764"}, {"mentions": [{"startOffset": 2474, "endOffset": 2493}], "type": "ORG", "entityId": "Q4920672"}, {"mentions": [{"startOffset": 2523, "endOffset": 2533}], "type": "NAT", "entityId": "Q1318423"}, {"mentions": [{"startOffset": 2568, "endOffset": 2576}], "type": "SUBSTANCE", "entityId": "Q243547"}, {"mentions": [{"startOffset": 2586, "endOffset": 2596}], "type": "DISEASE", "entityId": "Q4340209"}, {"mentions": [{"startOffset": 2611, "endOffset": 2626}], "type": "LOC", "entityId": "Q7983933"}, {"mentions": [{"startOffset": 2630, "endOffset": 2637}], "type": "LOC", "entityId": "Q657126"}, {"mentions": [{"startOffset": 2689, "endOffset": 2697}], "type": "SUBSTANCE", "entityId": "Q243547"}, {"mentions": [{"startOffset": 2720, "endOffset": 2740}], "type": "DISEASE", "entityId": "Q42844"}, {"mentions": [{"startOffset": 2782, "endOffset": 2796}], "type": "SUBSTANCE", "entityId": "Q76560"}, {"mentions": [{"startOffset": 2797, "endOffset": 2807}], "type": "TREATMENT", "entityId": "Q179661"}, {"mentions": [{"startOffset": 2937, "endOffset": 2939}], "type": "LOC", "entityId": "Q30"}, {"mentions": [{"startOffset": 2995, "endOffset": 3004}], "type": "TREATMENT", "entityId": "Q179661"}, {"mentions": [{"startOffset": 3201, "endOffset": 3209}], "type": "SUBSTANCE", "entityId": "Q243547"}, {"mentions": [{"startOffset": 3245, "endOffset": 3254}], "type": "TREATMENT", "entityId": "Q179661"}, {"mentions": [{"startOffset": 3282, "endOffset": 3292}], "type": "TREATMENT", "entityId": "Q179661"}, {"mentions": [{"startOffset": 3329, "endOffset": 3337}], "type": "SUBSTANCE", "entityId": "Q243547"}, {"mentions": [{"startOffset": 3370, "endOffset": 3384}], "type": "TREATMENT", "entityId": "Q76560"}, {"mentions": [{"startOffset": 3497, "endOffset": 3511}], "type": "TREATMENT", "entityId": "Q76560"}, {"mentions": [{"startOffset": 3512, "endOffset": 3522}], "type": "TREATMENT", "entityId": "Q179661"}]}}, "documentMetadata": {"title": ["Special K: ketamine\u2019s road from tranquilliser to possible antidepressant"], "language": ["en"], "direction": ["ltr"], "published_date": ["2013-01-12T05:00:00.000Z"], "accessed_date": ["2020-08-10T17:51:28"], "url": ["https://theconversation.com/special-k-ketamines-road-from-tranquilliser-to-possible-antidepressant-8766"], "domain": ["theconversation.com"], "conversation_tags": ["https://theconversation.com/topics/antidepressants-1013", "https://theconversation.com/topics/illicit-drugs-671", "https://theconversation.com/topics/depression-669", "https://theconversation.com/topics/mental-illness-2084", "https://theconversation.com/topics/mental-health-343"], "author": ["Colleen Loo"], "lead_image_url": "https://images.theconversation.com/files/18416/original/9hcbx7gy-1354772116.jpg?ixlib=rb-1.1.0&q=45&auto=format&w=1356&h=668&fit=crop", "word_count": ["555"], "uuid": ["95ecd5f1a54b3691bdfe94aad5e1f15e"], "license": ["//creativecommons.org/licenses/by-nd/4.0/"], "annotators": ["ANN_0", "ANN_1"], "adjudicators": ["ADJ_0", "ADJ_1"]}}
